Active Not Recruiting OBSERVATIONAL NCT05057637

The Impact of Optical Coherence Tomography on the Endovascular Treatment Planning of Femoropopliteal Disease (Optimo)

The Impact of Optical Coherence Tomography on the Decision-making Process of Endovascular Treatment of Femoropopliteal Disease

Sponsor: Abbott

Conditions Femoropopliteal Stenosis

Interventions Optical coherence tomography measurements

Updated 9 times since 2021 Last updated: Jan 5, 2026 Started: Mar 9, 2022 Primary completion: Dec 12, 2025 Completion: Apr 30, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Femoropopliteal Stenosis and is currently ongoing. Abbott leads this study, which shows 9 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Feb 2026 — Present [monthly]

Active Not Recruiting
Sep 2025 — Feb 2026 [monthly]

Active Not Recruiting

Status: Recruiting → Active Not Recruiting
May 2025 — Sep 2025 [monthly]

Recruiting
Dec 2024 — May 2025 [monthly]

Recruiting
Sep 2024 — Dec 2024 [monthly]

Recruiting

▶ Show 4 earlier versions

Jul 2024 — Sep 2024 [monthly]

Recruiting
Sep 2023 — Jul 2024 [monthly]

Recruiting
Jun 2022 — Sep 2023 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Oct 2021 — Jun 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott
Rijnstate Hospital
University of Twente

Data source: Rijnstate Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Arnhem, Netherlands